Bluebird Bio's therapies have an one-time cost of nearly $3 million each. "World's Most Expensive Drugs Can't Cure What Ails This Biotech -- Heard on the Street," at 9:00 a.m. ET, incorrectly said that each drug had an annual cost of nearly $3 million.
(END) Dow Jones Newswires
October 03, 2022 10:49 ET (14:49 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.